Aquestive Therapeutics Inc (AQST)
5.15
-0.37
(-6.70%)
USD |
NASDAQ |
Nov 04, 16:00
5.05
-0.10
(-1.94%)
Pre-Market: 08:39
Aquestive Therapeutics Total Liabilities (Quarterly): 153.08M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 153.08M |
March 31, 2024 | 165.82M |
December 31, 2023 | 163.90M |
September 30, 2023 | 162.38M |
June 30, 2023 | 163.64M |
March 31, 2023 | 170.52M |
December 31, 2022 | 175.62M |
September 30, 2022 | 159.66M |
June 30, 2022 | 152.67M |
March 31, 2022 | 149.67M |
December 31, 2021 | 144.13M |
September 30, 2021 | 125.64M |
June 30, 2021 | 120.64M |
March 31, 2021 | 113.72M |
Date | Value |
---|---|
December 31, 2020 | 111.38M |
September 30, 2020 | 86.94M |
June 30, 2020 | 84.93M |
March 31, 2020 | 85.32M |
December 31, 2019 | 84.60M |
September 30, 2019 | 83.28M |
June 30, 2019 | 75.06M |
March 31, 2019 | 74.04M |
December 31, 2018 | 76.77M |
September 30, 2018 | 66.57M |
June 30, 2018 | 78.79M |
March 31, 2018 | 68.90M |
December 31, 2017 | 69.61M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
84.60M
Minimum
Dec 2019
175.62M
Maximum
Dec 2022
135.49M
Average
149.67M
Median
Mar 2022
Total Liabilities (Quarterly) Benchmarks
ACADIA Pharmaceuticals Inc | 397.40M |
Rockwell Medical Inc | 29.53M |
Cormedix Inc | 18.87M |
Geovax Labs Inc | 6.404M |
Myomo Inc | 6.513M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 117.60M |
Shareholders Equity (Quarterly) | -35.48M |
Debt to Equity Ratio | -0.8464 |
Current Ratio | 7.486 |
Net Debt Paydown Yield | 1.04% |